Metraipolis › archive › dc_2e4cd9285363
Senotherapeutics in Malignant Brain Cancer Therapy — Europe PMC PMID:41350483
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41350483
- DOI
- 10.1007/s11912-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T21:18:59.013Z
- SHA-256 of the archived text
f906db412897313410e5f73bcbc7cbfffd21ffae8ef573c8221fb1ae6a21869b- Stable URL of this page
https://metraipolis.com/documento/dc_2e4cd9285363
How to cite
Senotherapeutics in Malignant Brain Cancer Therapy — Europe PMC PMID:41350483 — Europe PMC (en), https://europepmc.org/article/MED/41350483 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2e4cd9285363 (Metraipolis archive dc_2e4cd9285363, sha256 f906db412897313410e5f73bcbc7cbfffd21ffae8ef573c8221fb1ae6a21869b)
BibTeX
@misc{dc2e4cd9285363,
title = {Senotherapeutics in Malignant Brain Cancer Therapy — Europe PMC PMID:41350483},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41350483},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2e4cd9285363; sha256 f906db412897313410e5f73bcbc7cbfffd21ffae8ef573c8221fb1ae6a21869b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41350483. Agents can read the archived copy with the MCP tool read_document.